Photo taken from Sonia Guedan/X
Aug 4, 2024, 10:24
Sonia Guedan: TECELRA to become the first engineered cell therapy for a solid tumor cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, shared a post on X:
“TECELRA (afamitresgene autoleucel) has become the first engineered cell therapy for a solid tumor cancer approved by the U.S. FDA.
Congratulations to Adaptimmune and everyone involved in achieving this incredible milestone!“
Read further.
Source: Sonia Guedan/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 02:00
Sep 7, 2025, 23:56
Sep 7, 2025, 23:47
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25